anti-IL-23 therapeutic (Guardian Therapeutics)

N/A

Report date: 2025/03/14 16:48:58
NME

Base Information

Drug Nameanti-IL-23 therapeutic (Guardian Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer
Mechanisms of ActionInterleukin-23 modulators
TargetsInterleukin-23
Therapy Area/IndicationsGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGuardian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGuardian Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A